Related Experiment Video
Updated: Dec 31, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications
Guntulu Sık1, Asuman Demirbuga1, Agageldi Annayev1
1Acıbadem Mehmet Ali Aydınlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.
Insights
Therapeutic plasma exchange (TPE) is safe and effective for critically ill children, with an overall survival rate of 78.5%. This pediatric intensive care study highlights sepsis and hematological diseases as key indications for TPE.
Area of Science:
- Pediatric Critical Care Medicine
- Extracorporeal Therapies
- Intensive Care Unit Management
Background:
- Therapeutic plasma exchange (TPE) is a recognized treatment for various conditions.
- Application of TPE in pediatric patients presents unique challenges due to access and technical considerations.
- Critically ill children often require advanced life support, including TPE, for severe conditions.
Purpose of the Study:
- To evaluate the safety, clinical indications, and outcomes of TPE in critically ill pediatric patients.
- To identify patient subgroups and conditions associated with TPE efficacy and complications.
- To assess the feasibility and impact of TPE in a tertiary care pediatric intensive care unit.
Main Methods:
- Retrospective analysis of all TPE procedures performed in a pediatric intensive care unit from 2015 to 2019.
- Inclusion of 135 critically ill pediatric patients requiring TPE, with detailed data collection on demographics, indications, and treatments.
- Evaluation of procedural complications, replacement fluids, anticoagulants, and survival rates.
Main Results:
- A total of 635 TPE procedures were performed. Sepsis with multiple organ failure (44.4%) was the primary indication, followed by hematological (19.2%) and neurological (9.6%) diseases.
- The overall survival rate was 78.5%. Non-survivors exhibited significantly higher rates of organ failure, PRISM scores, and need for invasive ventilation.
- Procedural complications occurred in 16.3% of cases, with fresh frozen plasma (90.4%) and acid citrate dextrose solution (79.3%) being the most common replacement fluid and anticoagulant, respectively.
Conclusions:
- Therapeutic plasma exchange is a safe and effective treatment modality for critically ill pediatric patients when performed in facilities with appropriate medical and technical resources.
- While TPE in children carries inherent risks, experienced centers can minimize complications.
- Outcomes are generally favorable, but vary based on the underlying clinical indication and patient severity.
Abstract:
Therapeutic plasma exchange (TPE) is an effective treatment method in selective indications. Secondary to access and technical features, it is more difficult to apply in pediatric population than adults. The aim of this study is investigate safety, clinical indications, and results of this method in critically ill pediatric patients who need TPE treatment. All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 4 years (2015-2019) were evaluated retrospectively. TPE procedures (635) were performed for 135 patients. Median age was 34 months (10-108). Ninety-seven patients had mechanical ventilation support. Sepsis with multiple organ failure was the most frequent indication and accounted for 44.4% (n = 60) of the indications followed by hematological and neurological diseases (19.2% and 9.6% respectively). TPE was performed alone in 469 cases (73.9%), in combination with continuous renal replacement therapy in 154 cases (24.2%), and additional to extracorporeal membrane oxygenation in 12 cases (1.9%). Hematological disease and sepsis subgroups had the highest intubation rate, mechanical ventilation period, PRISM score, organ failure count, and mortality. Fresh frozen plasma (FFP) was the most frequently used replacement fluid in 90.4% of the procedures. The most frequent anticoagulant used in TPE was acid citrate dextrose solution (79.3%). Procedural complications were detected in 104 cases (16.3%) and occurred during TPE sessions. Overall survival rate was 78.5%. We found that the non-survivor group had significantly higher rates of organ failures (P = 0.0001), higher PRISM scores on admission (P = 0.0001), and higher rates of invasive ventilation support needed (P = 0.012). TPE is a treatment method which can be safely provided in healthcare facilities with necessary medical and technical requirements. Although it is riskier to provide such treatment to critically ill children, complications can be minimized in experienced healthcare facilities. Overall results are good and can vary depending on indication.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury V: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

